分类: health

  • Nigeria confirms Ebola case linked to East Africa

    Nigeria confirms Ebola case linked to East Africa

    A new chapter of uncertainty has opened for public health authorities across West Africa after Nigeria confirmed its first case of Ebola, linked to the ongoing deadly outbreak that has swept through East and Central Africa since May this year. The infected patient, a female who traveled from Uganda to Nigeria’s capital city of Abuja, has received a formal diagnosis through definitive laboratory testing, Nigeria’s Health Minister Muhammad Ali Pate announced.

    Following her admission to an Abuja hospital, the patient has been placed in isolation and is currently receiving targeted medical care. Local and national health teams have already launched urgent contact tracing operations to monitor individuals who have had close interactions with the infected woman, with 44 close contacts already identified for monitoring.

    This development marks the first confirmed Ebola case in a West African nation connected to the current outbreak centered in Central and East Africa. Notably, Nigeria brings prior experience to its response: the country successfully contained and eliminated an Ebola outbreak in 2014 that resulted in at least eight deaths, giving public health teams a foundation of knowledge for this new response.

    Ebola is a rare but severe viral disease with a high mortality rate. As symptoms progress, patients typically develop vomiting and diarrhea, which can progress to organ failure. While not all patients experience bleeding, many develop internal and external hemorrhaging as the illness advances. Transmission occurs through direct contact with bodily fluids — including blood and vomit — from an infected individual.

    According to data from the European Centre for Disease Prevention and Control, the current outbreak, which originated in the Democratic Republic of Congo this past May, has already killed at least 4,600 people and recorded more than 9,500 confirmed cases. The outbreak is driven by the Bundibugyo strain of Ebola, an uncommon variant for which no specific vaccine or targeted treatment has yet received formal approval, though multiple clinical trials for countermeasures are currently in progress.

    After the initial outbreak was declared in DRC, the virus spread to neighboring Uganda, where two people died from the disease. Uganda officially declared itself Ebola-free in August following the discharge of its last confirmed patient. The virus has since spread further to Kenya, where nine confirmed infections have been recorded. In response to the dual risks of Ebola and other security concerns, the United States issued a travel advisory on Monday urging its citizens to reconsider travel to Kenya due to elevated health risks.

    In anticipation of a possible imported case, Nigeria had already ramped up cross-border and travel-related disease surveillance in recent months. The Nigeria Centre for Disease Control has issued clear public health guidance for international travelers, requiring anyone arriving from countries with active Ebola transmission to complete a mandatory health declaration form. Travelers from non-affected countries are currently exempt from this requirement. The agency has also urged all incoming travelers to remain alert for symptoms and seek immediate medical care if they develop any signs consistent with Ebola infection.

  • Christina Applegate says she was wrongfully diagnosed with MS

    Christina Applegate says she was wrongfully diagnosed with MS

    Hollywood veteran Christina Applegate, famous for her roles in hit productions including *Anchorman* and *Married… with Children*, has opened up about a devastating medical mistake: she spent five years believing she lived with multiple sclerosis (MS), only to recently learn her initial diagnosis was incorrect. The star shared the shocking news in a new episode of her podcast *Messy*, released this Tuesday, marking the end of a brief hiatus she took to process the unexpected revelation.

    Applegate made clear that far from celebrating the correction, she was overwhelmed with frustration and tears when she received the news. “You don’t get misdiagnosed and then all of the sudden I’m better,” she explained to listeners. “If anything, I’ve gotten worse.” After five years of adjusting to life with a presumed chronic autoimmune condition, she now finds herself back at the very start of her medical journey. “I’m back at square one where I don’t know what’s going on with me,” she added. A full investigation to identify the root cause of her daily, debilitating symptoms is scheduled to launch next week.

    The chain of discoveries that led to the corrected diagnosis began a few years ago, when Applegate’s treating physician suggested pausing her regular MS infusion therapy to monitor her body’s response. During the treatment break, Applegate’s reaction did not align with what clinicians would expect for a confirmed MS patient. Prompted by this inconsistency, doctors conducted a deeper review of her case, ultimately concluding she had never had the autoimmune disease, which typically causes muscle stiffness and impaired mobility, speech, and coordination. Recalling the moment her doctor delivered the news, Applegate said: “She came into my room and said, ‘Congratulations, you don’t have MS.’ I was, like, not happy at all. Everybody else was so happy.”

    Joined on the podcast episode by guest Dr. Marwa Kaisey and co-host Jamie Sigler, Applegate’s conversation also shed light on a broader systemic issue in MS care. Dr. Kaisey explained that MS misdiagnoses are far more common than many patients realize, rooted in the condition’s inconsistent presentation and the lack of a single, definitive diagnostic test. Roughly one in five people told they have MS actually receive an incorrect diagnosis, the doctor noted. “It’s not like we have something like a pregnancy test that says ‘yes, you have it. No, you don’t,’” Dr. Kaisey said. “It’s a list of criteria.”

    Applegate first announced her MS diagnosis publicly in August 2021, after months of experiencing unexplained symptoms. At the time, she framed her prognosis as a challenging but manageable new chapter, writing: “It’s been a tough road. But as we all know, the road keeps on going.” In the years following her initial diagnosis, however, Applegate spoke openly about her declining health and deepening emotional distress. Earlier in 2024, she told listeners she was stuck in “real depression,” admitting: “I don’t enjoy living. I don’t enjoy it. I don’t enjoy things anymore.” In a prior interview with *The New York Times*, she shared that she could no longer walk without a cane, and relied on a wheelchair throughout production of her hit Netflix series *Dead to Me*.

  • Residents warned not to drink tap water after hundreds fall sick near South Africa capital

    Residents warned not to drink tap water after hundreds fall sick near South Africa capital

    In the Tshwane metropolitan area encompassing South Africa’s capital city of Pretoria, a new public health emergency has emerged after contaminated water left more than 400 people sickened and prompted officials to issue an urgent advisory for residents to avoid using tap water for consumption or cooking. Over a two-week monitoring period, local hospitals recorded hundreds of cases of acute gastrointestinal illness marked by severe stomach cramps and diarrhoea, with most patients being children under the age of four. While no fatalities have been reported in this outbreak, laboratory testing confirmed high levels of E. coli bacteria in the regional water supply. Additional testing also identified other harmful pathogens including norovirus, campylobacter, and shigella – all agents linked to acute gastrointestinal illness. The latest contamination incident adds to a troubling pattern of repeated waterborne disease outbreaks in the region surrounding Pretoria over the last several years. In 2023, a cholera outbreak in the Hammanskraal township, located just outside Pretoria, killed 29 people and was traced back to inadequate water purification protocols. Then in 2025, 48 confirmed cases of typhoid were recorded in the same eastern Pretoria region, though the source of that outbreak has never been officially identified. In the current incident, no cholera bacteria has been detected in water samples. In a joint statement released on Monday, South Africa’s Department of Water and Sanitation and Department of Health confirmed that 408 cases were recorded between October 7 and October 18 across five local townships. Early investigations point to failures at the local water treatment facility that supplies these communities, with officials confirming that exposure to contaminated water from this facility is the direct cause of the current outbreak. Investigators also found that local authorities failed to issue a timely warning to residents after the contamination was first detected. The regional water supply has now formally been declared unfit for human consumption, with officials urging residents to only use tap water for non-essential purposes such as flushing toilets. Emergency response teams have already dispatched a fleet of water tankers to deliver clean, potable water to affected communities. Officials have also issued guidance for residents, advising them to dispose of any previously stored tap water and disinfect all water storage containers using standard household bleach. Public health officials are continuing to monitor the situation closely, with ongoing testing of water sources and contact tracing to prevent further spread of illness.

  • Pope’s family ‘going through a lot’ as brother also undergoes cancer treatment, wife says

    Pope’s family ‘going through a lot’ as brother also undergoes cancer treatment, wife says

    In a startling revelation that has drawn global attention to the health of one of the world’s most prominent religious families, Louis Prevost, the eldest brother of Pope Leo XIV — the first American-born head of the Roman Catholic Church — has confirmed he is currently undergoing active treatment for a form of blood cancer, just hours after the Pope completed what the Vatican has called a completely successful lung cancer surgery.

    Deborah Prevost, Louis Prevost’s wife, spoke publicly about her husband’s condition in an interview with CBS News, the U.S. partner of the BBC, on Tuesday. She shared that Louis has been diagnosed with multiple myeloma, a blood cancer that impacts bone marrow and often affects kidney function. According to the UK’s National Health Service (NHS), while multiple myeloma remains incurable at this time, the Multiple Myeloma Research Foundation notes that patient survival rates have improved dramatically over the last 10 years, thanks to advances in new treatment modalities.

    Louis Prevost later confirmed the diagnosis in a separate interview with U.S. news outlet Newsmax, adding that he is currently receiving CAR-T cell therapy as part of a clinical trial at a Florida hospital, where the couple resides. CAR-T therapy is an innovative immunotherapy treatment that works by reprogramming a patient’s own immune cells to identify and eliminate cancerous blood cells. The 71-year-old pontiff’s brother-in-law also shared that Louis was first diagnosed with cancer back in 2017, completed a round of treatment in 2019, and saw his cancer go into remission before relapsing three months ago.

    The news of Louis Prevost’s ongoing cancer battle broke on the exact same day that 71-year-old Pope Leo underwent a scheduled 90-minute lung cancer surgery at Rome’s Gemelli Hospital. Following the procedure, the Vatican released an official medical bulletin confirming that surgeons removed the lower lobe of the Pope’s right lung after identifying a lung nodule during a routine pre-operative check-up. Post-surgery testing confirmed the growth was lung adenocarcinoma, the most common form of lung cancer, which develops in mucus-producing cells typically located in the outer regions of the lung.

    Vatican officials emphasized that the surgery went entirely according to plan with no reported complications. “The operation was successful and there were no complications,” the Vatican statement read. “After the operation, the Pope awoke normally and returned after a brief period of observation to his room.” On Wednesday morning, the Vatican updated the public on the pontiff’s recovery, noting he had enjoyed a “peaceful night” and is expected to remain hospitalized for approximately one week of monitored recovery.

    Speaking to reporters, Deborah Prevost acknowledged that the entire family is navigating an extraordinarily challenging period, but emphasized that they are remaining optimistic for both Louis and the Pope. “We’re going through a lot right now, but we’re keeping our spirits up for both of them,” she said, adding that the brothers spoke by phone last week shortly before Louis was set to check into the hospital for his most recent treatment. “He called to let us know what would be happening,” she said, referencing Pope Leo’s plan to undergo surgery shortly after the call. The Pope had publicly announced his upcoming surgery on Sunday, after the lung nodule was detected during a routine medical examination.

    Louis Prevost shared that he was caught off guard by the news of his brother’s cancer diagnosis, but has received positive updates on the pontiff’s post-surgery condition. “I got a message from his right hand that he was out of surgery, awake, feeling good, and was in no pain,” he told Newsmax’s Finnerty programme. “So, we were all in high hopes and high spirits hoping for the best.” Deborah Prevost echoed that sentiment, reaffirming the family’s reliance on faith during this difficult stretch: “We keep praying, keeping spirits up for both of them.”

    Medical experts note that long-term outcomes for lung adenocarcinoma depend on a range of factors, most notably the stage at which the cancer is detected and the patient’s overall pre-existing health. Early detection is consistently linked to far better prognoses, and treatment options for all forms of lung cancer have improved substantially over the past 20 years, with many early-stage cases achieving long-term remission after surgical intervention.

  • Kenya confirms second Ebola case as relative of country’s first victim

    Kenya confirms second Ebola case as relative of country’s first victim

    Ten days after a cross-border traveler from the Democratic Republic of the Congo (DR Congo) died from Ebola in Kenya’s capital Nairobi, East African health authorities have announced a second confirmed case of the deadly virus, in a development that has sparked targeted public health action while reassuring the general population. Kenya’s Ministry of Health confirmed the new patient is a 39-year-old man who is a close contact of the first victim. The man had already been placed in precautionary quarantine when he developed symptoms of Ebola on Tuesday, giving responders a head start in containing the potential spread. Ebola’s incubation period ranges between two and 21 days, meaning people exposed to the virus can remain asymptomatic and undetectable for up to three weeks after contact with an infected person. Health officials note that this early detection of the second case is a critical win for Kenya’s outbreak response: it has significantly boosted the patient’s odds of survival, while drastically reducing the risk that he could transmit the virus to other people. In an official statement, the ministry urged Kenyan residents to “stay calm but vigilant”, emphasizing that both confirmed cases are directly linked, with no evidence to suggest the virus has spread into the broader community. The first case, a 40-year-old Kenyan businessman, passed away on October 5, just a short time after he was admitted to a Nairobi hospital. He had traveled from DR Congo to Kenya via Uganda, and his infection was not detected at any border checkpoint before he entered the country. A relative picked him up from the airport and transported him directly to the hospital when he began showing signs of illness. In the weeks following the first patient’s death, contact tracers have worked around the clock to identify every person who may have been exposed to the virus. As of Tuesday, officials had located 113 of the 128 identified contacts, according to the Ministry of Health. Of those found, 108 are currently in monitored quarantine in Kenya, while tracing efforts continue for the remaining 15 people who have not yet been located. This confirmation of a second case in Kenya comes amid an ongoing, devastating Ebola outbreak in DR Congo that began in May of this year. Caused by the rare Bundibugyo strain of Ebola — a variant with no currently approved vaccine or specific antiviral treatment, though clinical trials for new countermeasures are ongoing — the outbreak has already claimed more than 4,000 lives in DR Congo, making it the second deadliest Ebola outbreak ever recorded. The Ebola virus itself is transmitted only through direct contact with bodily fluids of an infected person, such as blood or vomit, a key detail that public health officials have emphasized to reduce unnecessary public panic.

  • Pope walking and recovering ‘as expected’ after surgery, doctors say

    Pope walking and recovering ‘as expected’ after surgery, doctors say

    Just one day after undergoing a successful radical lung cancer surgery at Rome’s Gemelli Hospital, 71-year-old Pope Leo XIV is recovering on track, according to an official medical update released by the Vatican.

    The approximately 90-minute procedure, carried out on Tuesday afternoon, removed the entire lower lobe of the pontiff’s right lung to fully eliminate the cancerous growth. Medical teams confirmed post-surgery pathology testing that the nodule discovered pre-operation was an early-stage lung adenocarcinoma, a common form of lung cancer, matching pre-operative diagnostic suspicions.

    In their latest bulletin, the doctors reported that the Pope has already begun short walks, returned to a normal diet, and completed scheduled respiratory physiotherapy to aid recovery. Early Wednesday morning, blood work and a chest X-ray confirmed his body is healing normally, and the pontiff had a restful, uninterrupted night in his hospital room after waking smoothly from anesthesia following the operation.

    Pope Leo had publicly announced his upcoming surgery during his weekly Sunday address to crowds in St. Peter’s Square days earlier, noting that clinicians had detected a small, contained lung nodule at an early stage and recommended its removal. The Vatican has emphasized that the Pope, who is generally in good health, experienced no symptoms of illness or infection prior to the procedure. Medical teams are currently conducting additional screening to rule out any spread of the cancer to other parts of the body, and the pontiff is expected to remain in the hospital for roughly one week of monitored recovery.

    The news of the Pope’s lung cancer diagnosis has prompted widespread concern among global Catholic communities, many of whom still hold fresh memories of repeated hospital visits for Pope Francis, Leo’s predecessor who passed away last year. Pope Francis himself had part of a lung removed during his youth and later dealt with recurring respiratory issues.

    Clinical context explains that lung adenocarcinomas form in mucus-producing lung cells, ranking among the most prevalent forms of lung cancer. Long-term outcomes for patients with this diagnosis depend heavily on the stage of the cancer at detection and the individual’s baseline health — outcomes have improved significantly in recent decades, and early detection, such as in the Pope’s case, is linked to far better prognoses.

  • Questions remain over Ebola patient who travelled across three nations undetected

    Questions remain over Ebola patient who travelled across three nations undetected

    A 40-year-old Kenyan businessman who contracted Ebola in the Democratic Republic of Congo (DRC) has become Kenya’s first confirmed case of the deadly virus, and died just two days after his diagnosis at a Nairobi hospital on October 5. His cross-border journey that went entirely undetected by health authorities has sparked urgent scrutiny of biosecurity protocols across Central and East Africa amid one of the worst Ebola outbreaks on record.

    The man, who had lived and worked in DRC for seven years, traveled across three Congolese provinces—all of which had confirmed Ebola transmission by early October, according to the World Health Organization (WHO). He spent most of late August and early September in Bas-Uélé province, where a case had already been confirmed in Buta before his visit, though no definitive link to his infection has been established.

    Symptoms first emerged around September 15. After an initial consultation where he was prescribed antibiotics and sent home, he was admitted to a local health center in Bondo four days later. Even with fever and a rash consistent with early-stage Ebola, clinicians misdiagnosed him with a common skin infection and never administered an Ebola test. The overlapping early symptoms between Ebola and other widespread regional illnesses like malaria often complicate quick diagnosis, health officials note.

    On September 20, the businessman flew to Kisangani, the capital of Tshopo province, where he sought further treatment for more than 10 days. No details have been released about the facilities that treated him there. On October 1, more than two weeks after he first fell ill, he flew domestically to Beni before traveling to Kasindi, a busy border town in North Kivu—the province at the epicenter of DRC’s current outbreak, which has recorded more than 1,755 infections and over 1,000 deaths to date. He crossed the border into Uganda the same day.

    Uganda implemented movement restrictions along its DRC border shortly after the outbreak began in May, and successfully eliminated community transmission by August. But the hundreds of kilometers of remote, uncontrolled border territory makes full surveillance extremely challenging. It remains unclear whether the man passed through an official health checkpoint when entering the country.

    From the Ugandan border, he traveled overland to Kampala, then to Entebbe International Airport, where he boarded a commercial flight to Nairobi on October 3. Officials reported his temperature was normal during screening, allowing him to board without further inspection. Public health experts say this case exposes a critical flaw in the widespread reliance on temperature checks and self-declaration of symptoms to screen for Ebola. Dr. Wessam Mankoula, emergency director for the Africa Centres for Disease Control and Prevention (Africa CDC), noted that the patient’s medications could have suppressed his fever, or he may have simply been between fever spikes when he was screened.

    The pattern repeated at Jomo Kenyatta International Airport in Nairobi: he passed screening without issue, and a relative drove him directly to a private Nairobi Hospital. By that point, he was experiencing severe Ebola symptoms including fever, chills, muscle pain, sore throat, and internal bleeding. Laboratory tests confirmed he was infected with the Bundibugyo Ebola strain, the same variant driving the ongoing DRC outbreak. He was placed in isolation but his condition declined rapidly, and he died two days later. His funeral was conducted under strict biosecurity protocols to prevent transmission.

    As of the latest update, nearly 70 potential contacts of the patient have been placed under quarantine in Nairobi, with 66 identified in Kenya to date. Contact tracing efforts are ongoing in Uganda and DRC, and health officials expect the number of people monitored for exposure to rise. Concerns have also been raised among Kenyan healthcare workers about quarantine protocols and how the patient was handled at Nairobi Hospital. Kenyan health authorities say they have screened more than 650,000 travelers, trained nearly 5,000 healthcare workers in Ebola response, and designated five specialized facilities to treat confirmed cases.

    DRC’s current outbreak is the second deadliest Ebola outbreak ever recorded, with more than 4,000 fatalities reported so far this year. Africa CDC has completed a full reconstruction of the patient’s six-week journey, which revealed multiple missed opportunities to detect his infection and prevent potential community spread across three countries.

    In comments on the investigation, Dr. Mankoula emphasized that early reporting of symptoms is critical to both improving survival odds and stopping cross-border spread. “When you reveal any Ebola-related symptoms early, you’re not only preventing the virus spreading to other countries but you’re also protecting yourself first,” he said.

    The WHO has warned that social stigma around Ebola remains a major barrier to outbreak control, discouraging people from reporting symptoms or seeking prompt care. In DRC, misinformation claiming the virus does not exist has even led to violent attacks on health workers. The agency says it is ramping up public outreach to reduce fear and correct misinformation across affected regions. Ebola spreads through direct contact with infected bodily fluids or contaminated materials, and has an incubation period of 2 to 21 days, meaning exposed people can travel long distances before showing symptoms.

  • What is pneumonic plague and how does it spread?

    What is pneumonic plague and how does it spread?

    The World Health Organization has formally requested additional information from Russian authorities following the death of an employee at a Siberian plague research facility, a development that has sparked widespread public speculation amid unclear circumstances surrounding the fatality. While Russian officials are continuing their investigative work to pinpoint the exact cause of death, they have confirmed that all individuals who had close contact with the deceased researcher have returned negative tests for pneumonic plague – the most aggressive strain of the disease. To contextualize this ongoing investigation, public health experts have broken down key facts about pneumonic plague, its risks, and the importance of ongoing research into the pathogen.

    Plague, an infectious disease caused by the bacterium *Yersinia pestis*, occurs in three distinct forms in humans. Bubonic plague, the most common variant, targets the lymphatic system, while septicaemic plague infects the bloodstream. Pneumonic plague, the deadliest and rarest form, develops as a severe lung infection that can either arise when an existing bubonic or septicaemic infection spreads to the lungs, or be transmitted directly between humans through inhalation of infected respiratory droplets. This form of transmission typically requires prolonged close contact with an infected individual.

    Global case data for all three plague variants shows between 1,000 and 3,000 confirmed infections reported annually, most of which are bubonic plague. While the majority of cases are concentrated in central Africa, endemic reservoirs of the bacteria persist in wild rodent populations across every inhabited continent, including Russia, China, India, and the United States. Experts stress that plague is not a historical relic: around 200 rodent species are capable of carrying *Yersinia pestis*, meaning sporadic human infections will continue to occur long after the major medieval Black Death outbreak that killed millions across 14th-century Europe, which many researchers suspect was driven in large part by pneumonic plague.

    “Plague itself has not disappeared: the bacterium that causes it, Yersinia pestis, persists in animal reservoirs across many parts of the world,” explained Piero Olliaro, Professor of Poverty-Related Infectious Diseases at the University of Oxford. “Around 200 rodent species can harbour the bacterium, with reservoirs found across the Americas, Eurasia and Africa. Sporadic human cases therefore continue to occur, but established surveillance, infection-control measures and effective antibiotic treatment are important tools for limiting their impact.”

    While many members of the public find the idea of studying live plague bacteria in laboratories alarming, researchers say this work is critical to protecting global public health. “Plague is not a historical disease. It remains endemic in rodent populations across Africa, Asia and the Americas, and human cases occur every year, including outbreaks of the pneumonic form,” noted Zania Stamataki, Associate Professor of Viral Immunology at the University of Birmingham. “Diagnostics, vaccine development and surveillance for antibiotic resistance all require laboratories that hold and study the live organism. This work is vital to prepare against outbreaks.”

    Pneumonic plague is characterized by an extremely short incubation period, sometimes as brief as 24 hours, and medical experts warn that the disease is almost always fatal if not diagnosed and treated rapidly. Some clinical reference materials even note 100% mortality for untreated cases, though accurate modern data is limited. The good news, however, is that the infection responds very effectively to common antibiotics when treatment is initiated early. As a precautionary measure, people who have had high-risk exposure to pneumonic plague are often prescribed preventative antibiotics and placed in quarantine to stop potential spread.

    As the investigation into the Siberian lab death continues, Russian authorities have released preliminary findings noting that tests found “no microorganisms associated with the patient’s professional activities,” leaving the cause of death unconfirmed at this stage. International health authorities have reacted to the news with varying levels of engagement: former US President Donald Trump stated that Washington was examining the case closely, while the U.S. Centers for Disease Control and Prevention confirmed there was “no indication of a broader threat to the United States.” The UK’s Health and Safety Authority also noted it was requesting additional details, but assessed the risk to the British public as “very low.”

  • Kenya confirms its first Ebola death as outbreak spreads

    Kenya confirms its first Ebola death as outbreak spreads

    In a development that has raised regional public health alarms, Kenya has officially recorded its first confirmed case of Ebola, marking the first cross-border transmission of the rare Bundibugyo strain from the ongoing deadly outbreak in the Democratic Republic of the Congo (DRC). The patient was a Kenyan national who had resided in the DRC for seven years prior to his journey to the East African nation.

    According to Kenya’s Health Minister Aden Duale, the man began showing symptoms of the virus approximately one month ago, and sought care at multiple medical facilities across the DRC before beginning his trip to Nairobi. His journey to Kenya followed an overland route from eastern DRC to Uganda’s capital Kampala, where he boarded a commercial flight bound for Nairobi on Saturday. Upon arrival at Nairobi’s main international airport, the patient passed through routine public health screenings without raising immediate concern, before being transported to a local city hospital by a family member.

    After being admitted to Nairobi Hospital, the patient was quickly moved to a specialized isolation facility originally constructed during the global COVID-19 pandemic. It was at this facility that he developed the full suite of classic Ebola symptoms: high fever, chills, extreme fatigue and muscle weakness, painful difficulty swallowing, widespread muscle pain, and subcutaneous bleeding. Based on these telltale symptoms and the patient’s documented travel history from an active Ebola outbreak zone, attending clinicians immediately suspected a viral hemorrhagic fever and collected clinical samples for confirmatory testing. Those tests returned a positive result for the Bundibugyo strain of Ebola, Duale confirmed.

    The patient succumbed to the virus at 23:30 local time on Monday (20:30 GMT), just days after arriving in Nairobi. His burial is scheduled for Tuesday, conducted in strict adherence to international public health safety protocols designed to prevent further transmission of the highly contagious virus.

    As of Tuesday, Kenyan public health officials have identified at least 28 close contacts of the patient, including family members who accompanied him and healthcare workers involved in his treatment and care. Contact tracers are additionally working to locate and monitor 23 passengers and four crew members who were on the same commercial flight from Kampala to Nairobi as the infected patient.

    The current outbreak of Bundibugyo Ebola, which the DRC first declared in May 2024, is already the second deadliest Ebola outbreak ever recorded. By the time the first case emerged in Kenya, the WHO had logged 8,463 confirmed cases across the DRC, with 4,082 confirmed deaths. Shortly after the outbreak was declared in the DRC, Uganda detected two cases, both of which were fatal. However, the World Health Organization officially declared Uganda free of Ebola transmission in August, and no additional cases had been recorded outside the DRC until Kenya’s confirmation this week.

    Unlike the more common Zaire strain of Ebola, which has multiple approved vaccines and targeted treatments, the Bundibugyo strain is exceptionally rare and currently has no licensed vaccines or specific antiviral therapies available to combat infection. A small number of candidate medical countermeasures have been evaluated in clinical trials, but none have yet received full regulatory approval for widespread use.

    This is a developing breaking news story, and updates will be published as more information becomes available to public health authorities.

  • US ‘watching closely’ after plague researcher dies in Russia, Rubio says

    US ‘watching closely’ after plague researcher dies in Russia, Rubio says

    Following the death of a laboratory technician at a Siberian plague research institute, global health authorities are moving to assess potential risks tied to the incident, with U.S. Secretary of State Marco Rubio confirming that American officials are keeping the situation under close observation.

    The deceased, identified by Russian media as 20-something Daria, died recently after working at the Anti-Plague Institute of Siberia and the Far East in Irkutsk. Multiple unconfirmed reports have emerged surrounding the circumstances of her infection: one suggests she became ill after accidentally breaking a test tube containing the Yersinia pestis pathogen, while another notes she had recently taken a field trip to Buryatia, a region bordering Mongolia where the bacteria is naturally endemic in wild rodent populations such as marmots.

    Regional officials have released mixed updates on the cause of death. Irkutsk Governor Igor Kobzev stated that the preliminary cause of death has been recorded as “pneumonia of undetermined etiology”, adding that testing of Daria’s biological samples found no trace of the micro-organisms she worked with at the institute. Quoting Russia’s federal consumer health and safety watchdog Rospotrebnadzor, Kobzev also confirmed that no other staff from the institute have sought medical care for related symptoms, and a specialized biosafety inspection of the facility found no emergency situation. As a precautionary measure, Russian media reported last week that roughly 200 people who had contact with Daria are currently under medical observation.

    Kremlin spokesperson Dmitry Peskov has moved to quell public speculation, urging citizens to disregard unsubstantiated rumors and only trust official statements released by Rospotrebnadzor.

    In comments to reporters this week, U.S. Secretary of State Marco Rubio addressed American monitoring of the incident. “It seems that there was a worker at the lab that was infected and there’s concern that that, you know, could have spread, at least internally — you’ve seen them do quarantine of this and that nature,” Rubio said. “If something like that gets out, it can quickly spread. So we’re watching and monitoring it closely. I don’t think it’s cause for alarm, but it is cause for focus and the cause to just keep an eye on it and we’re doing that.”

    Public health experts have weighed in on the risks associated with the incident, noting that while pneumonic plague — the most infectious form of the disease caused by Yersinia pestis — carries a high fatality rate when left untreated, it can be effectively cured with prompt antibiotic treatment. Dr. Simon Clarke, an associate professor of cellular microbiology at the University of Reading, explained that the primary source of concern stems from the fact that pneumonic plague can transmit from person to person, which explains the proactive precautionary measures taken by Russian authorities.

    Clarke also pushed back against widespread public anxiety that echoes the disruptive lockdowns and safety measures seen during the COVID-19 pandemic, noting that such measures are extremely unlikely to be needed in this case. He added that while the pathogen could theoretically be studied for use as a biological weapon, the far more plausible explanation is that the potential exposure occurred either through natural contact in the endemic region or an accidental lab incident.

    Clarke emphasized that plague is not a disease of the past: Yersinia pestis remains endemic in many parts of the world, including regions of Russia, which justifies ongoing research into the bacteria. The Anti-Plague Institute of Siberia and the Far East at the center of this incident was founded just over 100 years ago in response to a major regional outbreak in the 1920s, and has long conducted critical research into plague prevention and treatment.